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Abstract 
Malignant brain tumors are among the deadliest neoplasms with the lowest survival rates of any cancer 
type. In considering surgical tumor resection, suboptimal extent of resection is linked to poor clinical 
outcomes and lower overall survival rates. Currently available tools for intraoperative histopathological 
assessment require an average of 20 minutes processing and are of limited diagnostic quality for 
guiding surgeries. Consequently, there is an unaddressed need for a rapid imaging technique to guide 
maximal resection of brain tumors. Working towards this goal, presented here is an all optical non-
contact label-free reflection mode photoacoustic remote sensing (PARS) microscope. By using a 
tunable excitation laser, PARS takes advantage of the endogenous optical absorption peaks of DNA 
and cytoplasm to achieve virtual contrast analogous to standard hematoxylin and eosin (H&E) staining. 
In conjunction, a fast 266 nm excitation is used to generate large grossing scans and rapidly assess 
small fields in real-time with hematoxylin-like contrast. Images obtained using this technique show 
comparable quality and contrast to the current standard for histopathological assessment of brain 
tissues. Using the proposed method, rapid, high-throughput, histological-like imaging was achieved in 
unstained brain tissues, indicating PARS’ utility for intraoperative guidance to improve extent of 
surgical resection. 
1 Introduction 
With some of the lowest median survival rates of any type of neoplasm, malignant brain tumors are 
among the deadliest of diseases1.  The current standard of care for brain tumors is surgical resection, as 
treatment options are limited by the potential for damage to critical functions of brain tissue, and 
modest sensitivity to cancer drugs and radiation2. During resection, the surgeon must carefully decide 
what tissue to remove such that a maximal extent of tumor resection is achieved without significant 
neurologic damage to optimize patient outcomes3,4. In the case of diffusely infiltrating gliomas, the 
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most common primary brain tumor, maximal safe resections confer a significant increase in survival 
time for patients3,4. Hence, increasing extent of resection is regarded as an essential factor in improving 
glioma patient outcomes3,4. 
Resection surgeries are guided by preoperative computed tomography (CT) and intraoperative 
magnetic resonance imaging (MRI), along with intraoperative neuropathologic analysis5-7. While MRI 
rapidly provides spatial information and reveals dense tumor regions, histopathology is used for 
identifying microscopic tissue properties, differentiating gliosis vs. healthy tissue, white vs. gray matter 
and necrotic vs. living tissues. Currently, frozen pathology is the main histopathological technique used 
intraoperatively. However, frozen histology can only be performed on a macroscopically representative 
subset of resected tissue, and each such sample requires an average of 20 minutes of processing8,9. 
Additionally, this method is prone to tissue distortion and difficulties with interpretation compared to 
formalin-fixed paraffin-embedded preparations, thereby providing suboptimal information to the 
surgeon10. 
In an effort to reduce reliance on suboptimal neuropathology, recent works have explored 
supplementing traditional MRI with methods such as fluid-attenuated inversion recovery (FLAIR) 
MRI11. While FLAIR successfully highlights areas of diffusely infiltrating tumor, it also captures 
demyelination, cerebral edema, and surgery-related injury potentially driving excess resection and 
unnecessary neurological damage to patients11. Furthermore, this method is slow, and like standard 
MRI lacks microscopic precision, contrast and tissue specificity11,12.  Outside MRI, some researchers 
have explored tumor identification using in-situ fluorescence microscopy12. However, these 
fluorescence methods are only effective in identifying high grade gliomas, are prone to error from 
obscuration in the surgical space, depend on exogenous dyes and lack discrimination between regions 
of tissue13. Consequently, there is no substitute for intraoperative histopathology when guiding 
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resection surgeries. Hence, there remains an urgent need for a rapid interoperative in-situ 
histopathological imaging technique to aid in safely and maximally resecting brain tumors. 
One modality which has shown promise as a label-free histopathological imaging technique is optical 
resolution photoacoustic microscopy (OR-PAM), a hybrid optomechanical modality which visualizes 
endogenous optical absorption contrast. In OR-PAM, a pulsed excitation laser is used to generate 
acoustic pressure waves which are then observed with an acoustically coupled ultrasound 
transducer14,15. By targeting absorption peaks characteristic of specific biomolecules, OR-PAM has 
demonstrated label-free microscopy of subcellular tissue features16. Using UV excitation to visualize 
DNA, recent works have provided exemplary histology like imaging in human breast tissue and murine 
brain tissues14,15,16. Within brain tissues, OR-PAM has provided rapid histological imaging of entire 
brain tissue slices using a multifocal UV excitation15. However, these UV based OR-PAM systems 
require physical contact to form images. Within the neurosurgical operating field, physical coupling is 
infeasible due to the tight spatial constraints, sensitive tissues, and risk of infection.  Therefore, while 
UV-PAM has provided excellent histology-like results label free, there remains a need for an all-optical 
reflection-mode apparatus more appropriate for in-situ applications. 
Recently our team, for the first time, utilized photoacoustic remote sensing (PARS) microscopy to 
demonstrate nuclear and cellular structure imaging in unstained human tissue preparations17,18.  PARS 
operates by directing a nanosecond scale excitation pulse into the sample. As the target absorbs optical 
energy from the excitation laser it undergoes thermo-elastic expansion, resulting in nanosecond scale 
modulations in the local refractive index which can be read as back-reflected intensity variations of a 
second co-focused continuous-wave detection laser19,20. These intensity modulations are then 
proportional to the absorbed excitation energy19,20. In this way, the PARS imaging modality visualizes 
optical absorption contrast in biological samples with an all-optical label-free non-interferometric 
reflection-mode architecture. The ability to work in reflection mode, rather than requiring light 
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transmission through the target, permits imaging unprocessed thick (>1 mm) tissue samples. In this 
work we present a multiwavelength rapid acquisition PARS system designed to directly emulate the 
contrast of histopathological staining in human brain tissues, specifically the widely used hematoxylin 
and eosin (H&E) staining.  
2 Methods:  
2.1 System Architecture 
The system architecture is outlined in Figure 1. The 266 nm excitation source was a 10 mW, 20 kHz, 
0.6 ns pulsed laser (SNU-20F-10x, Teem Photonics). The tunable source was an Ekspla NT210, a 3ns 
pulsed 1 kHz laser. Excitation laser outputs were spatially filtered prior to combination with the 
detection beam using a 25 µm pinhole (P25C, Thorlabs) and 50 µm pinholes (P50C, Thorlabs) for the 
266 nm and tunable excitation respectively.  Spatial filtering is required as the selected excitation lasers 
produce astigmatic and highly elliptical beams, inappropriate for near diffraction limited focusing. The 
detection laser was a 1310 nm superluminescent diode (S5FC1018P. Thorlabs). Horizontally polarized 
detection passes through the polarizing beam splitter (CCM1-PBS254, Thorlabs) and is converted to a 
circular polarization state using a quarter wave plate (WPQ10M-1310, Thorlabs). The combined 
excitation and detection are passed through a 2D galvanometer mirror optical scanning system 
(GVS412, Thorlabs), then co-focused onto the sample with a 0.3 numerical-aperture 15x reflective 
objective lens (LMM-15X-UVV, Thorlabs). Circularly polarized back-reflected detection beam is 
shifted to a vertical polarization state by the quarter wave plate. The vertically polarized detection is 
directed through a long-pass filter (DMLP1000, Thorlab.), then focused with a condenser lens 
(ACL25416U, Thorlabs) onto an InGaS photodiode (PDB425C-AC, Thorlabs). The analogue output of 
the photodiode is then interpreted by a 14-bit digitizer (Gage Applied).  
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Figure 1: Simplified Schematic of the PARS system. Component labels are defined as follows: 
polarizing beam splitter (PBS), long-pass filter (LPF), quarter-wave plate (QWP), objective lens (OL), 
dichroic mirror (DM), fold mirror (m). 
 
2.2 Image Reconstruction 
Generation of a point scanned image was performed with two methods, optical scanning with galvo-
mirrors and mechanical scanning of the sample. In each case, upon input of an excitation pulse, the 
relative location of the interrogation in x and y, and a short sample of photodiode output was captured 
by a digitizer. To determine the PARS amplitude, the upper and lower envelopes of the photodiode 
signal were extracted and used to calculate the absolute magnitude. For the mirror scans, at each PARS 
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excitation the x and y mirror angles were recorded and used to determine the interrogation location. 
The scattered PARS data was then fitted to a cartesian grid using nearest neighbor search. Linear 
interpolation was applied across the fitted data to determine the appropriate signal for each image pixel. 
For the mechanical scans, the stage speed was adjusted to generate equidistant lateral spacing between 
interrogation points, directly generating a grid of PARS interrogations. For each single wavelength a 
colormap was applied to this gridded data to form a completed image. To generate the false color H&E 
images utilizing both 250 and 420 nm data, further processing was applied to the final data sets. First, 
segmentation was used to determine background from tissue based on nuclear signal density. Second, 
for tissue regions, pixel values were calculated based on a weighted mixing function between the 250 
nm and 420 nm data.  
2.3 Sample Preparation 
In this study, a variety of formalin fixed paraffin embedded (FFPE) brain tissue samples were selected 
for testing. From each FFPE tissue block, two adjacent 4 µm sections were cut and fixed to slides. One 
of these slides underwent traditional histopathological staining and was subsequently imaged using a 
conventional bright field microscope. Areas of interest for the histological diagnosis of brain tumors 
were then identified to test the functionality of the PARS system. The adjacent unstained slices were 
imaged using the PARS microscope such that a direct comparison could be made between PARS and 
the current gold standard for histopathological imaging. Formalin fixed paraffin embedded brain tissue 
samples were obtained under protocols approved by Research Ethics Board of Alberta (Protocol ID: 
HREBA.CC-18-0277) and University of Waterloo Health Research Ethics Committee (Humans: 
#40275). The ethics committees waived the requirement for patient consent as the selected samples 
were archival tissue no longer required for diagnostic purposes, and no patient identifiers were 
provided to the researchers. All experiments were performed in accordance with the requirements of 
the Government of Canada, Panel on Research Ethics Guidelines. 
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3 Results and Discussion 
In H&E staining, the hematoxylin dye stains cell nuclei while eosin dye marks cellular structure. In 
order to mimic the contrast of H&E and generate false-color PARS images, a 1 kHz tunable excitation 
laser was used to target the same biomolecules highlighted in H&E staining. Two excitation 
wavelengths were selected to conduct PARS imaging. The first wavelength, 250 nm, was selected to 
provide absorption contrast akin to hematoxylin staining of the nucleus by targeting the UV absorption 
peak of DNA16. The second wavelength, 420 nm, was selected to generate eosin-like cellular structure 
contrast by targeting cytochromes, a group of extra-nuclear and mitochondrial proteins found in 
eukaryotic cells21.  To compensate for limitations imposed by the slow repetition rate of the tunable 
laser, an additional fast 21 kHz 266 nm excitation laser was added.  
Considering the tunable excitation laser, recovering a 1 mm x 1 mm image with 900 nm lateral 
sampling steps requires 22 minutes per wavelength. Though these scans are limited by the slow 
repetition rate of the tunable laser, the dual wavelength contrast provides the first true PARS simulated 
H&E images. Assessing the individual wavelengths, the 250 nm excitation provided 580 ± 20 nm 
spatial resolution, while the 420 nm excitation provided 590 ± 20 nm resolution. Depending on factors 
such as the tissue structure, excitation beam quality, and objective lens, the excitation pulse energies 
ranged from 0.9nJ to 20 nJ . Though the presented specifications are not ideal for clinical use, this 
study validates the efficacy of the proposed PARS system in recovering true simulated H&E contrast 
using a non-contact and label-free microscope in unstained brain tissues. Moving forwards, many non-
technical improvements may be implemented such as incorporating faster, shorter pulsed lasers which 
would drastically reduce the excitation energy required while increasing the imaging speed.  
Currently, to mitigate speed limitations, the faster 266nm excitation provides rapid scanning 
capabilities. Images captured with the 266 nm laser used 0.9 to 20 nJ excitation pulses and delivered 
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2.5 ± 0.4 µm spatial resolution. Using the 266 nm excitation a 900 nm spatial sampled 1 mm x 1 mm 
area can be captured in under 1.5 minutes, compared to the 22 minutes required by the tunable laser. In 
addition to providing rapid grossing scans, smaller fields may be assessed rapidly with optical 
scanning. In the real-time mode, a 175 µm by 175 µm image, composed of 100,000 interrogation points 
is captured in 5 seconds, equivalent to a 0.2 fps frame rate. As with the tunable laser, the 266 nm 
excitation is still limited by repetition rate. While the 266 nm source is substantially faster than the 
tunable laser, the imaging speed could be improved by a factor of 50 (a frame rate of 10 FPS) using a 
1MHz excitation. Moving forwards, a faster laser will be implemented substantially increasing the 
imaging area, and real-time frame rate.  
Starting with the rapid acquisition system, the 266 nm laser was used to quickly image the unstained 
tissue samples with optical scanning. In this imaging mode, bulk tissue properties such as internuclear 
distance, nuclear density, cellular composition and organization can be observed, enabling 
differentiation of necrotic, or neoplastic tissue from healthy tissue. Figure 2a shows a standard 
brightfield image of solid tumor glioblastoma with microvascular proliferations outlined in red, where 
the tumor spread extends into the region not resected by the surgeon. In the PARS image from the 
adjacent unstained section, Figure 2b, the same tumor margins and microvascular proliferations can be 
identified. Using this real-time capable PARS system, diagnostic properties are recovered from 
unstained tissues. This represents a critical step towards intraoperatively providing near instantaneous 
histopathological assessment. 
In addition to real-time capabilities, the 266 nm laser’s relatively high repetition rate was leveraged to 
image large FOVs. The ability to quickly preview large regions of tissue is essential in histological 
analysis. Pathologists may be able to then use these images to scan a large field of tissue and select 
clinically relevant regions where further higher resolution imaging should be performed. Figure 2c 
shows a brightfield H&E image of malignant tissue where the blue outline and stars indicate necrotic 
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regions (lacking viable tumor cells with characteristic pseudopalisades) within this region a thrombotic 
vessel is outlined in purple. Bordering this, the red outline indicates solid tumoral tissue, and 
microvascular proliferations. In the PARS image taken from the adjacent unstained tissue section, 
similar bulk tissue properties, including the location of the thrombotic vessel can be observed (Figure 
2d). In the PARS image both the necrotic regions and the cell-dense solid tumor are indicated by the 
same boundaries as in the H&E image. The wide area and real time scanning functions presented here 
generate images where diagnostic characteristics can be rapidly recovered, allowing for easy 
differentiation of tissue regions.  However, these images are generated using a single UV wavelength 
resulting in images with only DNA contrast reminiscent of hematoxylins contribution to standard H&E 
histology. 
11 
 
 
Figure 2: PARS H&E images of unstained tissue in comparison to their standard histopathological 
preparations. The left column of images outlined in purple was taken with a brightfield microscope 
from an H&E stained slide requiring multiple steps of processing and staining (example shown at top 
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of column). The right column outlined in orange, was taken with the PARS system from unstained 
tissue (example shown at the top of column) therefore eliminating the need for sample processing. (a) 
A conventional bright field H&E image of glioblastoma with solid tumor and microvascular 
proliferations (red outlines). (b) A rapid acquisition PARS image of the adjacent unstained brain tissue 
sample, with the region of solid tumoral tissue, and microvascular proliferations (red outlines), as in 
(a). (c) A standard bright field histopathological H&E image of a glioblastoma sample with a largely 
necrotic region (blue lines and stars), a thrombotic vessel (purple outline), and a region of solid tumor 
with microvascular proliferations (red outline).  (d) A PARS image acquired in a rapid acquisition 
mode of the same section of glioblastoma tissue, with the largely necrotic region (blue line and stars) 
and thrombotic vessel (purple outline), and the solid tumor region with microvascular proliferations 
(red outline), as in (c). A close-up of tumor cells and microvascular proliferations at the boundary 
between these regions is shown enclosed in the green boxes. (e) A standard bright field 
histopathological H&E image of a brain tissue sample with infiltrating tumor cells, adjacent to solid 
tumor shown in a) – d). (f) A PARS multiwavelength simulated H&E image of the same section of 
brain tissue. 
 
To produce false-color PARS images with true H&E-like contrast the multiwavelength system was 
employed. Figure 2e and Figure 2f show a direct comparison between a standard brightfield H&E 
image of brain tissue with non-malignant gliosis and a PARS H&E-like false-color image of the 
adjacent section of tissue. The PARS image with nuclear and cytochrome contrast is nearly identical to 
the adjacent tissue section with standard H&E processing viewed with a transmission brightfield 
microscope. Subtle clinically relevant features are readily assessed in the PARS image including 
nuclear and cell morphology, nuclear density and cellular organization. The fidelity of the PARS H&E-
like images is further improved by reduction in the field of view. In Figure 3a and 3c, black arrows are 
used to indicate the location of perivascular oligodendrocytes, a relatively small but clinically relevant 
deformity observed in this brain tissue. The accompanying PARS H&E image of the adjacent unstained 
slices are shown in Figures 3b and 3d, respectively. These PARS emulated H&E images are 
qualitatively identical to the adjacent traditional H&E images, although it should be noted that some 
minor differences in cellular structure are expected as these images are from adjacent sections 4 µm 
apart, not from the same slice. Both techniques show easily identifiable perivascular oligodendrocytes, 
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denoted by similar black arrows. This is the first time such features have been identified from unstained 
tissues in an all optical reflection mode architecture. 
 
Figure 3: Standard brightfield histology, compared to PARS H&E. (a)(c) Small field of view standard 
H&E processed white matter tissue with gliosis; perivascular oligodendrocytes are indicated by the 
black arrows. (b)(d) High fidelity PARS emulated H&E images of adjacent tissue sections showing the 
same clusters of perivascular oligodendrocytes, marked with black arrows. 
 
The PARS architecture explored in this study does not provide depth information in a single interrogation 
like traditional photoacoustic microscopy. Though a variant of the PARS modality, coherence gated 
photoacoustic remote sensing microscopy has been proposed, which would provide depth information 
from a single PARS interrogation22. Currently, within thick tissues, PARS provides depth discrimination 
using optical sectioning. Leveraging the tight axial focus of the UV excitation, PARS can virtually 
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section micron scale layers of cellular morphology. By capturing a series of optically sectioned 
subsurface images PARS can then recover depth information. Using this strategy, PARS is able to assess 
subsurface nuclear contrast without modification to the sample.  While the current results use sectioned 
paraffin embedded brain tissues, the all-optical reflection mode architecture lends itself to imaging of 
thick tissue samples (>1mm). Previously this capability has been shown in thick formalin fixed paraffin 
embedded breast tissue blocks17. Moving forwards volumetric imaging will be explored in appropriate 
depth resolvable brain tissue samples, such as formalin fixed paraffin embedded tissue blocks, or freshly 
resected tissues.   
4 Conclusions 
The histological capabilities of the PARS system presented here are well suited to intraoperative 
guidance of tumor resection surgeries, potentially improving the ability to achieve maximal safe 
resection. The proposed real time capable PARS microscope has been proven to rapidly assess tissues 
enabling differentiation of gliosis from healthy tissue, necrotic from living tissues and white from gray 
matter in unstained brain tissue samples. Furthermore, by using a multiwavelength approach, PARS 
microscopy generated images of comparable quality to the current gold standard for brain tumor 
histopathological assessment. Presented here, subtle diagnostic features, oligodendrocytes, have been 
recovered from unstained human brain tissue for the first time using an all optical reflection mode 
microscopy system. Notably, the simulated H&E contrast provided by PARS means that if adopted, 
there may be little requirement to retrain pathologists to interpret a new image type. The provided 
imaging characteristics can significantly increase the information available to a clinician during 
neurosurgical resections and can significantly contribute towards an optimal surgical management of 
malignant brain tumors. To further improve the diagnostic utility of this device, development is 
focusing on the incorporation of faster repetition rate lasers and additional excitation wavelengths. 
These improvements will facilitate increased imaging speeds with larger imaging fields, while 
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providing further selective contrast for biomolecules such as lipids and hemoglobin18. While the 
present results demonstrate the capabilities of PARS in the histological analysis of preserved brain 
tissues, this method will soon be applied to unprocessed freshly resected human brain tissue samples. 
This work represents a significant step towards the development of a real-time in-situ surgical 
microscopy system for intraoperative histopathological assessment of the neurosurgical operative field. 
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